GH and IGFs

hrp0095p1-98 | GH and IGFs

Supporting the mental wellbeing of caregivers of children under growth hormone treatment: mix-methods evaluation of the Adhera® Caring Program.

hrp0095p1-99 | GH and IGFs

Survey to Investigate Adherence to Growth Hormone Treatment in Children: The Impact of COVID-19 Pandemic

hrp0095p1-100 | GH and IGFs

Aetiology of familial short stature in children diagnosed with growth hormone deficiency: what do the genes tell us?

hrp0095p1-101 | GH and IGFs

A rare heterozygous IGFI variant causing impaired IGF-I cleavage and postnatal growth failure: a novel disease mechanism with insights into IGF-I physiology

hrp0095p1-102 | GH and IGFs

Growth and Growth Delay in Children with Systemic Juvenile Idiopathic Arthritis: A Single Center Study

hrp0095p1-103 | GH and IGFs

A novel IGF1R variant in a child with mild IGF1 resistance, normal birth weight, mild short stature and microcephaly

hrp0095p1-104 | GH and IGFs

SARS-CoV-2 pandemic and GH treatment: new strategies to abate the distance

hrp0095p1-105 | GH and IGFs

Early Growth Failure and Untreated Growth Hormone Deficiency in Radiotherapy-Treated Long-Term Survivors of Childhood Brain Tumor

hrp0095p1-106 | GH and IGFs

Shox Deficiency in Children with Short Stature: Response To Recombinant Growth Hormone Therapy (rGH)

hrp0095p1-296 | GH and IGFs

No differences in adult height outcome with personalized approach to Growth Hormone dosing– but gender differences were found

hrp0095p1-297 | GH and IGFs

rhGH therapy in a patient with homozygous IGF1R mutation

hrp0095p1-298 | GH and IGFs

Use of PDE5 inhibitors as a potential treatment for isolated growth hormone deficiency caused by alternate splicing of GH1 gene.

hrp0095p1-299 | GH and IGFs

Three years of growth hormone (GH) treatment in young adults with PWS previously treated with GH during childhood: Effects on cognitive functioning

hrp0095p1-300 | GH and IGFs

Evaluation of the growth response of children with growth hormone deficiency according to peak growth hormone levels on provocative tests

hrp0095p1-301 | GH and IGFs

High prevalence of refractoriness in children tested for growth hormone deficiency with nocturnal spontaneous profile and subsequent arginine-insulin-tolerance test

hrp0095p1-302 | GH and IGFs

A novel heterozygous STAT5B variant in a patient with resistant atopic dermatitis and short stature.

hrp0095p1-303 | GH and IGFs

Short stature due to a novel missense variant (695C>A) in the GHR gene: a case report.

hrp0095p1-304 | GH and IGFs

Growth hormone deficiency and central hypothyroidism related to microarray abnormality involving a loss of ~111-kilobases (kb) within cytogenetic band Xq28 and a gain within cytogenetic band 20q11.22.

hrp0095p1-496 | GH and IGFs

The Effect of Anastrozole Treatment on Height Gain in Pubertal Boys on Growth Hormone Treatment

hrp0095p1-497 | GH and IGFs

Metabolomics profile of children with growth hormone deficiency

hrp0095p1-498 | GH and IGFs

A Long-Acting Growth Hormone Module For Paediatric Growth Hormone Deficiency In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions – The GloBE-Reg LAGH Study

hrp0095p1-499 | GH and IGFs

Long-term safety and effectiveness of recombinant human growth Hormone inKorean pediatric patients with growth disorders: 9-year interim analysis fromLG Growth Study

hrp0095p1-500 | GH and IGFs

A patient-centric approach to connected health solutions in paediatric growth hormone therapy

hrp0095p1-501 | GH and IGFs

IGFBP-3 assessment in the work-up of short stature

hrp0095p1-502 | GH and IGFs

A real life evaluation of rhGH efficacy in children born SGA

hrp0095p1-503 | GH and IGFs

Adult Height in Patients with Non-Permanent, Idiopathic and Isolated Growth Hormone Deficiency

hrp0095p1-504 | GH and IGFs

easypod^® Augmented Reality: Usability and acceptability of a virtual reality mobile solution to support training of patients on a connected injection device

ESPE Abstracts

60th Annual ESPE (ESPE 2022)

Poster Category 1

Supporting the mental wellbeing of caregivers of children under growth hormone treatment: mix-methods evaluation of the Adhera® Caring Program.

Survey to Investigate Adherence to Growth Hormone Treatment in Children: The Impact of COVID-19 Pandemic

Aetiology of familial short stature in children diagnosed with growth hormone deficiency: what do the genes tell us?

A rare heterozygous IGFI variant causing impaired IGF-I cleavage and postnatal growth failure: a novel disease mechanism with insights into IGF-I physiology

Growth and Growth Delay in Children with Systemic Juvenile Idiopathic Arthritis: A Single Center Study

A novel IGF1R variant in a child with mild IGF1 resistance, normal birth weight, mild short stature and microcephaly

SARS-CoV-2 pandemic and GH treatment: new strategies to abate the distance

Early Growth Failure and Untreated Growth Hormone Deficiency in Radiotherapy-Treated Long-Term Survivors of Childhood Brain Tumor

Shox Deficiency in Children with Short Stature: Response To Recombinant Growth Hormone Therapy (rGH)

No differences in adult height outcome with personalized approach to Growth Hormone dosing– but gender differences were found

rhGH therapy in a patient with homozygous IGF1R mutation

Use of PDE5 inhibitors as a potential treatment for isolated growth hormone deficiency caused by alternate splicing of GH1 gene.

Three years of growth hormone (GH) treatment in young adults with PWS previously treated with GH during childhood: Effects on cognitive functioning

Evaluation of the growth response of children with growth hormone deficiency according to peak growth hormone levels on provocative tests

High prevalence of refractoriness in children tested for growth hormone deficiency with nocturnal spontaneous profile and subsequent arginine-insulin-tolerance test

A novel heterozygous STAT5B variant in a patient with resistant atopic dermatitis and short stature.

Short stature due to a novel missense variant (695C>A) in the GHR gene: a case report.

Growth hormone deficiency and central hypothyroidism related to microarray abnormality involving a loss of ~111-kilobases (kb) within cytogenetic band Xq28 and a gain within cytogenetic band 20q11.22.

The Effect of Anastrozole Treatment on Height Gain in Pubertal Boys on Growth Hormone Treatment

Metabolomics profile of children with growth hormone deficiency

A Long-Acting Growth Hormone Module For Paediatric Growth Hormone Deficiency In The Global Registry For Novel Therapies In Rare Bone & Endocrine Conditions – The GloBE-Reg LAGH Study

Long-term safety and effectiveness of recombinant human growth Hormone inKorean pediatric patients with growth disorders: 9-year interim analysis fromLG Growth Study

A patient-centric approach to connected health solutions in paediatric growth hormone therapy

IGFBP-3 assessment in the work-up of short stature

A real life evaluation of rhGH efficacy in children born SGA

Adult Height in Patients with Non-Permanent, Idiopathic and Isolated Growth Hormone Deficiency

easypod^® Augmented Reality: Usability and acceptability of a virtual reality mobile solution to support training of patients on a connected injection device

BiosciAbstracts